CLARITY MEDICAL (01406) Reorganizes Special Committee and Independent Special Committee

Stock News11-11

CLARITY MEDICAL (01406) announced that the Board of Directors passed the following resolutions at a meeting held on November 11, 2025: (1) Immediate termination of PricewaterhouseCoopers Consulting Hong Kong Limited as the forensic advisor to the Special Committee; (2) Immediate restructuring of the Special Committee, with Ci Ying (appointed as an Independent Non-Executive Director on June 25, 2025) and Dr. Chen Pou-kin (newly appointed Independent Non-Executive Director at the Board meeting) replacing Ms. Zheng and Mr. Wang as members; and (3) Immediate restructuring of the Independent Special Committee, where Zheng Yuling and Wang Can will no longer serve as members, while Dr. Chen Pou-kin will join as a new member. Following this reorganization, the committee will consist of Li Jinhong (Chairman), Ms. Ci, and Dr. Chen Pou-kin.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment